$LIVN (LivaNova PLC)

$LIVN {{ '2016-08-01T13:58:08+0000' | timeago}} • Announcement

$LIVN said it appointed Damien McDonald as its new Chief Operating Officer (COO), effective Oct. 3, 2016. McDonald will report to CEO Andre-Michel Ballester as a member of its executive team and will be domiciled in London. The transition to its new realigned organization is expected to be completed by the end of 2016.

$LIVN {{ '2017-09-14T20:47:42+0000' | timeago}} • Announcement

$LIVN intends to invest in inorganic opportunities within adjacent and underserved markets. The company expects to achieve revenue growth in the mid-single-digits in the near term and high-single-digits in the long term. $LIVN anticipates compounded annual earnings per share growth in the low- to mid-teens from 2017 to 2022.

$LIVN {{ '2017-08-04T17:57:58+0000' | timeago}} • Announcement

Medical technology company $LIVN said its sutureless aortic heart valve Perceval was approved by the Centers for Medicare and Medicaid Services (CMS) for a New Technology Add-on Payment. CMS will reimburse hospitals for the Perceval valve procedure, starting October 1, 2017. The Perceval valve optimizes the surgical procedure.

$LIVN {{ '2017-07-12T12:45:32+0000' | timeago}} • Announcement

$LIVN appointed Keyna Skeffington as SVP and General Counsel. Skeffington most recently served as Vice President of Legal – Corporate and Securities, Deputy General Counsel and Assistant Secretary at $MDT.

$LIVN {{ '2017-06-29T15:56:55+0000' | timeago}} • Announcement

$LIVN received FDA approval of its VNS Therapy system in patients as young as four years of age with partial onset seizures that are refractory to antiepileptic medications.

$LIVN {{ '2017-06-21T14:06:24+0000' | timeago}} • Announcement

$LIVN said its latest VNS Therapy systems received FDA approval for expanded MRI labeling, affirming VNS Therapy as the only epilepsy device approved by the FDA for MRI scans. This ensures VNS patients with latest technology may visit any MRI center in US and have access to more than 90% of scans routinely performed on patients with epilepsy.

$LIVN {{ '2017-06-12T14:07:22+0000' | timeago}} • Announcement

$LIVN announced the appointment of Keyna Skeffington as SVP and General Counsel. She most recently served as VP of Legal – Corporate and Securities, Deputy General Counsel and Assistant Secretary at Medtronic PLC.

$LIVN {{ '2017-05-16T13:32:11+0000' | timeago}} • Announcement

$LIVN appointed Thad Huston as its new CFO, effective May 20, 2017. The company's former CFO Vivid Sehgal is coordinating with Huston to ensure an orderly transition. Huston will report directly to CEO Damien McDonald. Most recently, Huston served as Group CFO, Medical Devices at $JNJ.

$LIVN {{ '2017-05-03T12:53:24+0000' | timeago}} • Announcement

As a result of the Caisson Interventional acquisition, $LIVN expects to recognize a pretax non-cash gain during 2Q17 on the $15MM book value of its existing investment in Caisson. The acquisition will be dilutive to earnings for several years. The 2017 guidance will be updated to include the estimated impact of the acquisition.

$LIVN {{ '2017-05-03T12:53:08+0000' | timeago}} • Announcement

$LIVN acquired the remaining outstanding interests in Caisson Interventional, LLC. $LIVN agreed to pay up to $72MM, net of $6MM of debt forgiveness, to acquire the remaining 51% of the company. The first payment of $18MM was made at closing with the balance paid on a schedule driven primarily by regulatory approvals and sales earn-outs.

$LIVN {{ '2017-03-31T14:05:29+0000' | timeago}} • Announcement

Medical technology and innovation company $LIVN announced that its CFO, Vivid Sehgal, is leaving the company to pursue other opportunities. Sehgal will continue as CFO and will support an orderly transition to his successor while the company is underway with an external search to identify a replacement.

$LIVN {{ '2016-09-22T14:41:05+0000' | timeago}} • Announcement

Maker of medical devices $LIVN unveiled PLATINIUM, its new range of implantable cardiac defibrillators (ICDs) & cardiac resynchronization therapy devices (CRT-Ds). These models offer longevity of devices with service life projected to last over 14 years for single-chamber ICD, over 13 years for dual-chamber ICD and over 10 years for CRT-D devices.

$LIVN {{ '2016-08-29T11:26:56+0000' | timeago}} • Announcement

$LIVN announced long term results from the RESPOND-CRT clinical trial after an 18 month follow-up period. The trial was designed to investigate the clinical efficacy and safety of device-based optimization using $LIVN's proprietary SonR cardiac contractility sensor technology in patients with advanced heart failure.

$LIVN {{ '2016-08-01T13:58:08+0000' | timeago}} • Announcement

$LIVN said it appointed Damien McDonald as its new Chief Operating Officer (COO), effective Oct. 3, 2016. McDonald will report to CEO Andre-Michel Ballester as a member of its executive team and will be domiciled in London. The transition to its new realigned organization is expected to be completed by the end of 2016.

$LIVN {{ '2016-07-29T08:36:51+0000' | timeago}} • Announcement

$LIVN said it elected Andrea Saia to its BoD as a non-executive director. Saia brings considerable board and healthcare credentials to $LIVN following 11 years with $NVS as President and CEO of their CIBAVision subsidiary and as global head of their Vision Care Division.

$LIVN {{ '2016-07-29T05:44:54+0000' | timeago}} • Announcement

$LIVN said it received Canadian regulatory approval for its Memo 3D ReChord, a semirigid prosthetic annuloplasty ring for Mitral Valve Repair (MVR). MVR is an option, rather than mitral valve replacement, that can provide patients with improved heart function and preservation of lifestyle.

$LIVN {{ '2016-07-06T15:30:53+0000' | timeago}} • Announcement

$LIVN said it is implementing organizational re-design that, in addition to existing corporate support functions, will include a Chief Operating Officer (COO). In addition, Michel Darnaud, President of Cardiac Surgery, will assist in transition of Stefano Di Lullo retirement and will be retiring in 1Q of next year.

$LIVN {{ '2016-07-06T15:29:07+0000' | timeago}} • Announcement

$LIVN announced new organizational structure designed to strengthen execution and accountability of its business franchises, promote collaboration across global organization and support long-term profitable growth. Stefano Di Lullo, President of Cardiac Rhythm Management, has announced his intention to retire effective immediately.

$LIVN {{ '2016-03-08T15:34:36+0000' | timeago}} • Announcement

Medical technology company $LIVN said that it launched the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve. This device helps reduce the complexity of aortic valve replacement (AVR) by enhancing the speed and efficiency of the surgery, while providing optimized hemodynamic performance.

$LIVN {{ '2016-03-03T15:52:33+0000' | timeago}} • Announcement

Medical technology company $LIVN said that it has named Karen M. King as Vice President, Investor Relations and Corporate Communications. Earlier Ms. King was Corporate Vice President, Investor Relations at Hospira and was responsible for developing and executing strategies to build relationships with investment analysts and shareholders.

$LIVN {{ '2016-02-29T16:54:40+0000' | timeago}} • Announcement

Medical technology company $LIVN said it received an approval from Japan's Pharmaceutical and Medical Devices Agency (PMDA) for Solo Smart stentless tissue valve. Solo Smart valve that is fully biological is for patients with an active lifestyle, who are at risk of Patient Prosthesis Mismatch.

Recent Transcripts

MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
BABA (Alibaba Group Holding Limited)
Thursday, August 17 2017 - 11:30am
SNAP (Snap Inc.)
Thursday, August 10 2017 - 9:00pm
PIRS (Pieris Pharmaceuticals, Inc.)
Thursday, August 10 2017 - 2:00pm
LIVN (LivaNova PLC)
Wednesday, August 9 2017 - 1:00pm
RTIX (RTI Surgical Inc.)
Tuesday, August 8 2017 - 12:30pm
OFIX (Orthofix International N.V.)
Monday, August 7 2017 - 8:30pm
HAE (Haemonetics Corporation)
Monday, August 7 2017 - 12:00pm
FIT (Fitbit Inc.)
Wednesday, August 2 2017 - 9:00pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
WMGI (Wright Medical Group N.V.)
Wednesday, August 2 2017 - 8:30pm
VVV (Valvoline Inc.)
Wednesday, August 2 2017 - 3:00pm
NUVA (NuVasive, Inc.)
Thursday, July 27 2017 - 8:30pm
ESND (Essendant Inc.)
Thursday, July 27 2017 - 12:30pm
AMD (Advanced Micro Devices, Inc.)
Tuesday, July 25 2017 - 9:00pm
CRY (CryoLife Inc.)
Tuesday, July 25 2017 - 12:00pm
ARNC (Arconic Inc.)
Monday, July 24 2017 - 2:00pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
MDT (Medtronic plc)
Thursday, May 25 2017 - 12:00pm
BABA (Alibaba Group Holding Limited)
Thursday, May 18 2017 - 11:30am

AlphaGraphics you may like